Beta Bionics (BBNX) Net Equity Issued and Repurchased (2025)
Beta Bionics' (BBNX) quarterly Net Equity Issued and Repurchased came in at -$904000.0 in Q4 2025, down 100.46% quarter-over-quarter from $195.4 million in Q1 2025.
Powered by 
Analysis
Beta Bionics (BBNX) Net Equity Issued and Repurchased (2025) Analysis & Trends
Beta Bionics has disclosed Net Equity Issued and Repurchased across 1 years of filings, most recently posting -$904000.0 for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$904000.0; the TTM figure through Dec 2025 stood at $194.5 million (changed N/A YoY), while the FY2025 annual figure was $194.5 million, up 226.06% from the prior year.
- Net Equity Issued and Repurchased came in at -$904000.0 for Q4 2025 at Beta Bionics, down from $195.4 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $195.4 million in Q1 2025 to a low of -$904000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Beta Bionics | 786.45 Mn | 605.96 Mn | 18.90 Mn | - |